What is the price target for NIO?

What is the price target for NIO?

It also reported a record 91,429 delivered for all of 2021, which was a 109% increase from 2020. Among 25 analysts who cover Nio, the median price target on the beaten-down stock is currently $58.65, which is 166% higher than the current share price.5 days ago

What is the target price for Pfizer?

High $76.00 ------------- ------ Median $58.75 Low $49.00 Average $60.76 Current Price $54.33

What is the projected stock price for Moderna?

The 15 analysts offering 12-month price forecasts for Moderna Inc have a median target of 253.00, with a high estimate of 506.00 and a low estimate of 85.00. The median estimate represents a +54.16% increase from the last price of 164.12.

What is the target price for Mrna?

High $506.00 ------------- ------- Median $253.00 Low $85.00 Average $279.53 Current Price $159.47

Is Moderna stock undervalued?

Moderna Is Undervalued and Has Billions to Reinvest | Nasdaq.5 Jan 2022

Can I buy shares in Novavax?

Invest in Novavax, Inc. , you can buy Novavax, Inc. stock in any dollar amount, or any other fund or stock you know on Stash.

What is Nvax new price target?

High $315.00 ------------- ------- Median $266.00 Low $150.00 Average $250.00 Current Price $82.92

Is Dvax a good investment?

Dynavax Technologies Corporation - Buy Valuation metrics show that Dynavax Technologies Corporation may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of DVAX, demonstrate its potential to outperform the market.

Should I sell Dvax stock?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dynavax Technologies in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Dynavax Technologies stock.

Why did Dvax go up today?

Why Dynavax Stock Zoomed Higher Today On Tuesday, India's Biological E announced that its coronavirus vaccine candidate Corbevax had received approval for emergency use from that country's pharmaceutical regulator, the Drugs Controller General.3 days ago

Related Posts:

  1. How much will Palantir be worth in 5 years?
  2. The top three competitors and alternatives in the year 2021.
  3. Is there a website predicting stocks?
  4. Can I buy shares in Novavax?